Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced huntington's disease-like rat model

Nutritional Neuroscience

Volumn 14, Issue 3, 2011, Pages 106-111

  Tasset, I ^a   Pontes, A J ^a   Hinojosa, A J ^a   de la Torre, R ^b,c,d   Tunez I ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

3 nitropropionic acid; Extra virgin olive oil; Huntingon's disease; Hydroxytyrosol; Oxidative stress

Indexed keywords

GLUTATHIONE; HYDROXYTYROSOL; LIPID PEROXIDASE; OLIVE OIL; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BRAIN LEVEL; CALORIC INTAKE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HUNTINGTON DISEASE LIKE SYNDROME; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GLUTATHIONE; HUNTINGTON DISEASE; INJECTIONS, INTRAPERITONEAL; LIPID PEROXIDATION; MALE; NITRO COMPOUNDS; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; PLANT OILS; PROPIONIC ACIDS; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE;

RATTUS; RATTUS NORVEGICUS;

EID: 79959835822     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830511Y.0000000005     Document Type: Article

References (35)

1. Adibhatla RM, Hatcher JF. Lipid peroxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2010;12:125-69.
2. Túnez I, Sánchez F, Tasset I. The molecular bases of Huntington's disease: the role played by oxidative stress. Rev Neurol 2009;49:424-9.
3. Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrere I, Ros J, Cabiscol E. Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 2008;45:667-78
4. Quintanilla RA, Johnson GV. Role of mitochondiral dysfunction in the pathogenesis of Huntington's disease. Brain Res Bull 2009; 80:242-7.
5. Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007; 145:1233-48.
6. Brouillet E, Jacquard C, Bizat N, Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 2005;95:1521-40.
7. Browne SE, Beal MF. Oxidative damage in Huntington's disease pathogenesis. Antioxid Redox Signal 2006;8:2061-73.
8. Túnez I, Tasset I, Pérez de la Cruz V, Santamaría A. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules 2010;15:878-916.
9. Féart C, Samieri C, Rondeau V, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009;302:638-48.
10. Quiles JL, Ochoa JJ, Ramírez-Tortosa C, Battino M, Huertas JR, Martín Y, et al. Dietary fat type (virgen olive vs. Sunflower oils) affects age-related changes in DNA doublestrand-breaks, antioxidant capacity and blood lipids in rats. Exp Gerontol 2004;39:1189-98.
11. Covas MI, Nyyssönen K, Poulsen HE, Kaikkonen J, Zunft HJ, Kiesewetter H, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 2006;145:333-41
12. Fitó M, de la Torre R, Covas MI. Olive oil and oxidative stress. Mol Nutr Food Res 2007;51:1215-24.
13. Gonza ́lez-Correa JA, Navas MD, López-Villodres JA, Trujillo M, Espartero JL, de la Cruz JP. Neuroprotective effect of hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neurosci Lett 2008;446:143-6.
14. Díaz RJ, Yago MD, Martínez-Victoria E, Naranjo JA, Martínez MA, Mañas M. Comparison of the effects of dietary sunflower oil and virgin oil on rat exocrine pancreatic secretion in vivo. Lipids 2003;38:1119-26.
15. Brouillet E, Condé F, Beal MF, Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 1999;9:427-68.
16. Fki I, Sahnoun Z, Sayadi S. Hypocholesterolemic effects of phenolic extracts and purified hydroxytyrosol recovered from olive mill wastewater in rats fed a cholesterol-rich diet. J Agric Food Chem 2007;55:624-31.
17. Strack A, Duffy CF, Malvey M, Arruaga EA. Individual mitochondrion characterization: a comparison of classical assays to capillary electrophoresis with lase-induced fluorescence detection. Ann Neurol 2001;294:141-7.
18. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Effectiveness of the Mediterranean diet: can it halp dalay or prevent Alzheimer's disease? J Alzheimer Dis 2010;20:795-801.
19. Pérez de la Cruz V, Elinos-Calderón D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverrí J, Ali SF, et al. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. Behav Brain Res 2009;1999:210-7.
20. Singh S, Misiak M, Beyer C, Arnold S. Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes. Glial 2009;57:1480-91.
21. Kumar P, Kalonia H, Kumar A. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acidinduced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease. Behav Pharmacol 2010;21:217-30.
22. Kumar P, Kumar A. Protective role of sertralina against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain. Indian J Exp Biol 2009;47:715-22.
23. Silva RH, Abílio VC, Kameda SR, Takatsu-Coleman AL, Carvalho RC, Ribeiro Rde A, et al. Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:65-70.
24. Túnez I, Montilla P, Muñoz MC, Feijóo M, Salcedo M. Protective effect of melatonin on 3-nitrorpopionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J Pineal Res 2004;37:252-6.
25. Borlongan CV, Koutouzis TK, Sanberg PR. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Lett 1998;251:173-6.
26. Brouillet E, Condé F, Beal MF, Hantraye P. Rreplicating Huntington's disease phenotype in experimental animals. Pror Neurobiol 1999;59:427-68.
27. Alemany R, Navarro MA, Vögler O, Perona JS, Osada J, Ruiz- Gutiérrez V. Olive oils modulate fatty acid content and signalling protein expression in apolipoprotein E knockout mice brain. Lipids 2010;45:53-61.
28. de la Cruz JP, del Río S, Arrebola MM, López-Villodres JA, Jebrouni N, González-Correa JA. Effect of virgen olive oil plus acetylsalicylic acid on brain slices damage alter hypoxiareoxygenation in rats with type 1-like diabetes mellitus. Neurosci Lett 2010;471:89-93.
29. Konstantinidou V, Covas MI, Muñoz-Aguayo D, Khymenets O, de la Torre R, Saez G, et al. In vivo nutrigenomic effects of virgen olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB 2010;24:2546-57.
30. Zhu L, Liu Z, Feng Z, Hao J, Shen W, Li X, et al. Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme system in retinal pigment epithelial cells. J Nutr Biochem 2010;21:1089-98.
31. Materljan E, Materljan M, Materljan B, Vlacic H, Baricev-Novakovic Z, Sepcic J. Multiple sclerosis and cancer in Croatia-a possible protective role of the 'Mediterranean diet'. Coll Antropol 2009;33:539-45.
32. Raederstorff D. Antioxidant activity of olive polyphenols in humans: a review. Int J Vitam Nutr Res 2010;79:152-65.
33. de la Torre R. Bioavailability of olive oil phenolic compounds in humans. Inflammopharmacology 2008;16:245-7.
34. Sandhir R, Mehrotra A, Kamboj SS. Lycopene prevents 3-nitropropionic mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 2010;57:579-87.
35. Kumar P, Padi SS, Naidu PS, Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 2006;17:485-92.